Your browser doesn't support javascript.
loading
Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting.
Barat, Eric C; Arrii, Marianne L E; Soubieux-Bourbon, Annaelle; Daouphars, Mikaël; Varin, Rémi; Tilleul, Patrick R.
Afiliación
  • Barat EC; Department of Pharmacy, CHU Rouen, Normandie University, UNICAEN, Inserm, U1086, Caen, France. Electronic address: eric.barat@chu-rouen.fr.
  • Arrii MLE; Department of Pharmacy, CHU Rouen, 76031, Rouen, Cedex, France.
  • Soubieux-Bourbon A; Department of Pharmacy, CHU Rouen, 76031, Rouen, Cedex, France.
  • Daouphars M; Department of Pharmacy, Henri Becquerel Cancer Center, 76038, Rouen, France.
  • Varin R; Department of Pharmacy, UNIROUEN, Inserm, U1234, CHU Rouen, Normandie University, Rouen, France.
  • Tilleul PR; AP-HP, Sorbonne Université- Pitié Salpêtrière, Paris, France.
Breast ; 72: 103588, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37857129
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biosimilares Farmacéuticos Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biosimilares Farmacéuticos Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article